Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15664-29-6

Post Buying Request

15664-29-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15664-29-6 Usage

Uses

Different sources of media describe the Uses of 15664-29-6 differently. You can refer to the following data:
1. Pheophorbide a is a chlorophyll-related compound studied for it’s anti-tumor & anti-cancer activity.
2. Pheophorbide-a has been used as a photosensitizer: for the photodynamic therapy (PDT) in oral cancer cell linesto test its effect on inducing oxidative stress and death in L. amazonensisto test its effect on the viability of HeLa cells

Biochem/physiol Actions

Pheophorbide-a, due to its photosensitizing effect, may serve as a promising bioactive compound to treat leishmaniasis. It is a metabolite of chlorophyll and possesses immunostimulation functionality. Pheophorbide-a is a photosensitizer for the photodynamic therapy. It is an ATP Binding Cassette Subfamily G Member 2 (ABCG2) transporter specific substrate. Overexpression of ATP-binding cassette (ABC) transporters in cancer cells is associated with the multidrug resistance phenotype.

Enzyme inhibitor

This chlorophyll a degradation intermediate (MW = 579.68 g/mol; CAS 15664-29-6), which is identical to chlorophyll a, except for the absence of the latter’s magnesium ion and ester at the 17-position, is obtained by acid hydrolysis of chlorophyll a. Pheophorbide a inhibits acyl-CoA:cholesterol acyltransferase and magnesium protoporphyrin IX methyltransferase, acts as an endothelin receptor antagonist, and also induces apoptosis. Pheophorbide a is also as an anti-tumor promoter.

Check Digit Verification of cas no

The CAS Registry Mumber 15664-29-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,6,6 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 15664-29:
(7*1)+(6*5)+(5*6)+(4*6)+(3*4)+(2*2)+(1*9)=116
116 % 10 = 6
So 15664-29-6 is a valid CAS Registry Number.

15664-29-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML1218)  Pheophorbide-a  ≥90% (HPLC)

  • 15664-29-6

  • SML1218-10MG

  • 609.57CNY

  • Detail
  • Sigma

  • (SML1218)  Pheophorbide-a  ≥90% (HPLC)

  • 15664-29-6

  • SML1218-50MG

  • 2,476.89CNY

  • Detail

15664-29-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name pheophorbide a

1.2 Other means of identification

Product number -
Other names Pheophorbide a

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15664-29-6 SDS

15664-29-6Synthetic route

pheophytin a
603-17-8

pheophytin a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
In water; trifluoroacetic acid at 0℃; for 0.916667h;92%
pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In acetone at 20 - 25℃; for 22h;80%
With hydrogenchloride; water In acetone at 20℃; for 24h;70%
Acidic aq. solution;
pheophytin a
603-17-8

pheophytin a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With trifluoroacetic acid In water at 0℃; for 1h; Inert atmosphere; Darkness;58%
With hydrogenchloride
With enzyme-substance from heracleum spondylium
chlorophyll-a
53321-11-2, 479-61-8

chlorophyll-a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride; water In diethyl ether at 0℃; for 0.5h;
pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether
methylchlorophyllide-a

methylchlorophyllide-a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride
Conditions
ConditionsYield
With trifluoroacetic acid In water at 0℃; for 1h; Inert atmosphere; Darkness;1.3 g
chlorophyllide α

chlorophyllide α

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In water; acetone at 25℃; Kinetics; pH-value;
With sulfuric acid In acetone at 20℃; Darkness;
With sulfuric acid
pheophytin a

pheophytin a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride; water In diethyl ether for 2h;Ca. 20 g
α-chlorophyll

α-chlorophyll

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
Stage #1: chlorophyll α With sulfuric acid In dichloromethane; water Darkness;
Stage #2: With sulfuric acid In methanol
With hydrogenchloride In diethyl ether; water at 0 - 5℃; for 0.5h;
chlorophyll a

chlorophyll a

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With hydrogenchloride In diethyl ether Inert atmosphere;
pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
In methanol; diethyl ether at 0℃; for 0.25h;95%
methanol
67-56-1

methanol

pheophorbide-a
15664-29-6

pheophorbide-a

Conditions
ConditionsYield
With pyridine; chloroformic acid ethyl ester In tetrahydrofuran for 0.166667h;88%
With hydrogenchloride
With chlorophyllase-substance
With sulfuric acid
pheophorbide-a
15664-29-6

pheophorbide-a

pyropheophorbide a
24533-72-0

pyropheophorbide a

Conditions
ConditionsYield
In 2,4,6-trimethyl-pyridine for 0.666667h; Reflux;85%
With pyridine for 5h; Heating;78%
With biphenyl
methanol
67-56-1

methanol

N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride
2389-48-2

N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride

pheophorbide-a
15664-29-6

pheophorbide-a

C48H62N6O9

C48H62N6O9

Conditions
ConditionsYield
Stage #1: pheophorbide-a With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 0.5h;
Stage #2: N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride In N,N-dimethyl-formamide for 1h;
Stage #3: methanol With sodium methylate for 8h;
85%
pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide a hydrazide

pheophorbide a hydrazide

Conditions
ConditionsYield
Stage #1: pheophorbide-a With 1-hydroxy-pyrrolidine-2,5-dione; 1,2-dichloro-ethane In dichloromethane at 20℃; for 0.5h;
Stage #2: With hydrazine In dichloromethane at 20℃; for 4h;
83%
ethylene glycol
107-21-1

ethylene glycol

pheophorbide-a
15664-29-6

pheophorbide-a

phoephorbide a ethylene glycol monoester
61774-49-0

phoephorbide a ethylene glycol monoester

Conditions
ConditionsYield
With pyridine; isobutyl chloroformate In tetrahydrofuran for 0.25h;72%
3-[(4Z,10Z,15Z,19Z)-(2S,3S)-18-(3-Amino-propylcarbamoyl)-13-ethyl-20-methoxycarbonylmethyl-3,7,12,17-tetramethyl-8-vinyl-2,3,22,24-tetrahydro-porphin-2-yl]-propionic acid methyl ester

3-[(4Z,10Z,15Z,19Z)-(2S,3S)-18-(3-Amino-propylcarbamoyl)-13-ethyl-20-methoxycarbonylmethyl-3,7,12,17-tetramethyl-8-vinyl-2,3,22,24-tetrahydro-porphin-2-yl]-propionic acid methyl ester

pheophorbide-a
15664-29-6

pheophorbide-a

C74H82N10O9
137445-88-6

C74H82N10O9

Conditions
ConditionsYield
With N-(3-dimethylaminopropyl)-N-ethylcarbodiimide67%
ethylenediamine
107-15-3

ethylenediamine

pheophorbide-a
15664-29-6

pheophorbide-a

C72H76N10O8

C72H76N10O8

Conditions
ConditionsYield
Stage #1: pheophorbide-a With pyridine; dichloromethane; di-tert-butyl dicarbonate at 0℃; for 0.5h;
Stage #2: ethylenediamine In dichloromethane at 20℃; for 2h;
67%
pheophorbide-a
15664-29-6

pheophorbide-a

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose
4064-06-6

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose

C47H54N4O10

C47H54N4O10

Conditions
ConditionsYield
With dmap; 2-chloro-1-methyl-pyridinium iodide In dichloromethane for 3h; Reflux;60%
pheophorbide-a
15664-29-6

pheophorbide-a

20-chloropheophorbide a

20-chloropheophorbide a

Conditions
ConditionsYield
With N-chloro-succinimide In dichloromethane Inert atmosphere;57%
pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-paclitaxel

pheophorbide-α-paclitaxel

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 4h;54%
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 4h;54%
doxorubicin hydrochloride
25316-40-9

doxorubicin hydrochloride

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-doxorubicin

pheophorbide-α-doxorubicin

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;53%
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;53%
phoephorbide a ethylene glycol monoester
61774-49-0

phoephorbide a ethylene glycol monoester

pheophorbide-a
15664-29-6

pheophorbide-a

bis(pheophorbide a)ethylene glycol diester
73197-83-8

bis(pheophorbide a)ethylene glycol diester

Conditions
ConditionsYield
With dmap; 1-methanesulfonyloxy-1,2,3-benzotriazole In dichloromethane for 2.16667h;47%
2-(hydroxymethyl)-6-exo-(1,7,7-trimethylbicyclo[2.2.1]-hept-2-yl)phenol

2-(hydroxymethyl)-6-exo-(1,7,7-trimethylbicyclo[2.2.1]-hept-2-yl)phenol

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide a 17-(2-hydroxy-3-(exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)benzyl)-benzyl ester

pheophorbide a 17-(2-hydroxy-3-(exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)benzyl)-benzyl ester

Conditions
ConditionsYield
Stage #1: pheophorbide-a With thionyl chloride
Stage #2: 2-(hydroxymethyl)-6-exo-(1,7,7-trimethylbicyclo[2.2.1]-hept-2-yl)phenol With triethylamine In dichloromethane at 25℃; for 8h;
46%
chlorin e6 13-N-(2-aminoethyl)amide-15,17-dimethyl ester

chlorin e6 13-N-(2-aminoethyl)amide-15,17-dimethyl ester

pheophorbide-a
15664-29-6

pheophorbide-a

15,17-dimethyl ester of e6-chlorinyl-13-N-[2-(N-17(3)-pheophorbidyl)aminoethyl]amide

15,17-dimethyl ester of e6-chlorinyl-13-N-[2-(N-17(3)-pheophorbidyl)aminoethyl]amide

Conditions
ConditionsYield
Stage #1: pheophorbide-a With pyridine; di-tert-butyl dicarbonate In dichloromethane at 0℃; for 0.25h;
Stage #2: chlorin e6 13-N-(2-aminoethyl)amide-15,17-dimethyl ester With pyridine In dichloromethane at 20℃; for 1h;
44%
pheophorbide-a
15664-29-6

pheophorbide-a

A

132-(methoxycarbonyl)phytoporphyrin
34705-25-4

132-(methoxycarbonyl)phytoporphyrin

B

132-(methoxycarbonyl)-31-oxophytoporphyrin
127594-32-5

132-(methoxycarbonyl)-31-oxophytoporphyrin

Conditions
ConditionsYield
With air; hydrogen iodide In acetic acid for 5h; Ambient temperature;A n/a
B 40%
4-aminobenzenemethanol
623-04-1

4-aminobenzenemethanol

pheophorbide-a
15664-29-6

pheophorbide-a

C42H43N5O5

C42H43N5O5

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;38%
4-aminobenzenemethanol
623-04-1

4-aminobenzenemethanol

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-4-aminobenzyl alcohol

pheophorbide-α-4-aminobenzyl alcohol

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 4h;38%
pheophorbide-a
15664-29-6

pheophorbide-a

purpurin 18
25465-77-4

purpurin 18

Conditions
ConditionsYield
With oxygen; potassium hydroxide In diethyl ether; isopropyl alcohol for 12h;34.4%
With 1,4-dioxane; propan-1-ol; potassium hydroxide weiteres Reagens: Aether; weitere Angaben: Erwaermen des Reaktionsprodukts in Dioxan;
With potassium hydroxide; oxygen In methanol
pheophorbide-a
15664-29-6

pheophorbide-a

sphingosine-1-phosphocholine

sphingosine-1-phosphocholine

C58H83N6O9P

C58H83N6O9P

Conditions
ConditionsYield
Stage #1: pheophorbide-a With HATU In N,N-dimethyl-formamide at 20℃; for 1h; Darkness; Inert atmosphere;
Stage #2: sphingosine-1-phosphocholine With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 24h; Darkness; Inert atmosphere;
30%
2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranosylamine
59044-96-1, 93079-64-2, 120575-75-9, 30854-63-8

2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-β-D-glucopyranosylamine

pheophorbide-a
15664-29-6

pheophorbide-a

C61H71N5O21

C61H71N5O21

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane at 20℃; for 4h;30%
pheophorbide-a
15664-29-6

pheophorbide-a

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose
4064-06-6

1,2:3,4-di-O-isopropylidene-α-D-galactopyranose

C58H70N4O15

C58H70N4O15

Conditions
ConditionsYield
With dmap; 2-chloro-1-methyl-pyridinium iodide In toluene for 3h; Reflux;30%
pheophorbide-a
15664-29-6

pheophorbide-a

(17S,18R)-174,18-lactonopheophorbide a

(17S,18R)-174,18-lactonopheophorbide a

Conditions
ConditionsYield
With 2,3-dicyano-5,6-dichloro-p-benzoquinone In chloroform at 20℃; for 0.5h;28.3%
pheophorbide-a
15664-29-6

pheophorbide-a

C49H55N5O13

C49H55N5O13

Conditions
ConditionsYield
With (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; triethylamine In dichloromethane at 20℃; for 4h;28%
C36H35NO13

C36H35NO13

pheophorbide-a
15664-29-6

pheophorbide-a

C71H69N5O17

C71H69N5O17

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃;24%
C36H35NO13
1338699-28-7

C36H35NO13

pheophorbide-a
15664-29-6

pheophorbide-a

pheophorbide-α-2-hydroxycinnamic acid-doxorubicin

pheophorbide-α-2-hydroxycinnamic acid-doxorubicin

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃;24%
pheophorbide-a
15664-29-6

pheophorbide-a

20-bromopheophorbide a

20-bromopheophorbide a

Conditions
ConditionsYield
With N-Bromosuccinimide In dichloromethane Inert atmosphere;10%

15664-29-6Related news

Original researchInvolvement of a Putative Bipartite Transit Peptide in Targeting Rice Pheophorbide A (cas 15664-29-6) Oxygenase into Chloroplasts for Chlorophyll Degradation during Leaf Senescence09/08/2019

Leaf senescence is one of the major factors contributing to the productivity and the grain quality in crops. The regulatory mechanism of leaf senescence remains largely unknown. Here, we report the identification and characterization of a rice early senescence 1 (eas1) mutant, which displayed an...detailed

Folate-modified PLGA nanoparticles for tumor-targeted delivery of Pheophorbide A (cas 15664-29-6) in vivo09/05/2019

Targeted drug delivery has been an important issue for tumor therapy including photodynamic therapy (PDT). The purpose of our study is to increase the targeting efficiency of photosensitizer (PS) using folate-modified nanoparticles (NPs) to tumor site in vivo. Folate receptor is over-expressed o...detailed

The photodynamic action of Pheophorbide A (cas 15664-29-6) induces cell death through oxidative stress in Leishmania amazonensis09/03/2019

Leishmaniasis is a disease caused by hemoflagellate protozoa, affecting millions of people worldwide. The difficulties of treating patients with this parasitosis include the limited efficacy and many side effects of the currently available drugs. Therefore, the search for new compounds with leis...detailed

Sodium Pheophorbide A (cas 15664-29-6) has photoactivated fungicidal activity against Pestalotiopsis neglecta09/01/2019

Sodium pheophorbide a (SPA) is a natural photosensitizer. To explore its antifungal activity and mechanism, we studied its inhibitory effects on spore germination and mycelial growth of Pestalotiopsis neglecta. We used sorbitol, 2-thiobarbituric acid (TBA) and electron microscopy to determine it...detailed

15664-29-6Relevant articles and documents

ELECTROPHILIC SUBSTITUTION AT THE δ-METHINE BRIDGE OF PHEOPHORBIDE a AND a'

Hynninen, Paavo H.,Loetjoenen, Simo

, p. 1845 - 1846 (1981)

A chloro-substituted derivative was prepared from chlorophyll a'.The derivative was shown to be δ-chloro-methyl pheophorbide a by UV/VIS, MS and 1H NMR.

Effect of dietary chlorophyll derivatives on mutagenesis and tumor cell growth

Chernomorsky, Simon,Segelman, Alvin,Poretz, Ronald D.

, p. 313 - 322 (1999)

Much attention in recent years has been given to the antigenotoxicity of chlorophyll. Chlorophyll, however, is known to be converted into pheophytin, pyropheophytin, and pheophorbide in processed vegetable food and following ingestion by humans. Studies were conducted on the antimutagenic and tumoricidal potencies of these compounds. All the chlorophyll derivatives tested exhibit identical antimutagenic effect towards 3-methylcholanthrene (3-MC), suggesting that the porphyrin nucleus may complex directly with the mutagen. It does not exclude, however, another mechanism of activity involving inactivation the enzymatic transformation of 3-MC. In contrast, the action of N'-nitro-N'-nitrosoguanidine (MNNG) depends upon structural differences between the chlorophyll derivatives. It is significantly lower when the phytol-containing pheophytin and pyropheophytin are tested as to that of the phytol-lacking pheophorbide. The higher concentrations of the chlorophyll derivatives were required to reduce the mutagenicity of MNNG than needed for 3-MC. The cytotoxicity of chlorophyll derivatives against tumor cells also was evaluated. The cellular uptake and inhibition of myeloma cell multiplicity were found to be greater for pheophorbide than for pheophytin. Calculated on the amount of cell associated chlorophyll derivative, however, pheophytin was more cytostatic/cytotoxic than pheophorbide. The results presented in this report indicate that food sources that yield chlorophyll derivatives may play a significant role in cancer prevention.

Design, synthesis and biological evaluation of novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives as potent photosensitizers for photodynamic therapy

Zhang, Xing-Jie,Han, Gui-Yan,Guo, Chang-Yong,Ma, Zhi-Qiang,Lin, Mei-Yu,Wang, Yuan,Miao, Zhen-Yuan,Zhang, Wan-Nian,Sheng, Chun-Quan,Yao, Jian-Zhong

, (2020)

This study aimed to improve the biological effectiveness and pharmacokinetic properties of chlorin e6, a second-generation photosensitizer (PS), for tumor photodynamic therapy (PDT). Herein, the novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives 3a, 3b, 3c and 8 were synthesized and their photophysical properties and in vitro bioactivities such as phototoxicity against A549, HeLa and melanoma B16–F10 cells, reactive oxygen species (ROS) production and subcellular localization were evaluated. In addition, preferred target compounds were also investigated for their in vivo pharmacokinetic in SD rats and in vivo antitumor efficacies in C57BL/6 mice bearing melanoma B16–F10 cells. Apparently, simultaneous introduction of amino acid residue and n-hexyloxy chain in chlorin e6 made a significant improvement in photophysical properties, ROS production, in vitro and in vivo PDT efficacy. Encouragingly, all target compounds showed higher in vitro phototoxicity than Talaporfin, and that 3c (152-Lys) exhibited strongest phototoxicity and highest dark toxicity/phototoxicity ratio, followed by 8 (131-Asp), 3a (152-Asp) and 3b (152-Glu). Moreover, in vivo PDT antitumor efficacy of 3a, 3c and 8 was all better than that of Talaporfin, and that both 3c and 8 had stronger PDT antitumor efficiency than 3a. The overall results suggested that these novel 31-hexyloxy chlorin e6-based 152- or 131-amino acid derivatives, especially 3c and 8, might be potential antitumor candidate drugs for clinical treatment of melanoma by PDT.

Synthesis of chlorins with a distal vinyl group

Mal'Shakova,Belykh,Kuchin

, p. 197 - 200 (2007)

A series of chlorins containing a vinyl group on the periphery of the chlorin ring that was attached by linkers of various length, potential monomers for synthesis of polymers containing chlorin via copolymerization, was synthesized from methylpheophorbide a.

Distribution of chlorophyll- and bacteriochlorophyll-derived photosensitizers in human blood plasma

Dandler, Joerg,Wilhelm, Brigitte,Scheer, Hugo

, p. 182 - 193 (2010)

Chlorophylla and, in particular, bacteriochlorophyll a derivatives are promising candidates for photosensitizers in photodynamic therapy. The distribution of 21 (bacterio)chlorophyll derivatives among human blood plasma fractions was studied by iodixanol gradient ultracentrifugation and in situ absorption spectroscopy. Modifications of the natural pigments involved the central metal (Mg2+, Zn2+, Pd2+, none), the isocyclic ring (closed, open and taurinated), substituents at C-3 (vinyl, acetyl, 1-hydroxyethyl) and C-173 (phytyl ester, free acid). Cellular blood components bound only a small fraction of the pigments. Distribution among low-density lipoproteins (LDL), high-density lipoproteins (HDL) and high-density proteins (HDP) of the plasma was influenced as follows: (1) application in Cremophor EL slightly altered pigment distribution by lipoprotein modification, (2) only very polar pigments with multiple hydrophilic substituents showed substantial HDP binding, (3) the presence of the esterifying alcohol at C-173 caused enrichment in LDL, this was more pronounced with bacteriochlorophylls than with chlorophylls, (4) substituents at C-3 had only little influence on the distribution, (5) Zn2+-complexes were enriched in HDL compared to Mg2+ and Pd2+ complexes, indicating specific binding of the former. Equilibration of pigments among the different fractions was largely complete within 3 h.

Amino acid derivatives of pyropheophorbide-a ethers as photosensitizer: Synthesis and photodynamic activity

Meng, Zhi,Shan, Bin,Zhang, Ling,Han, Gui-Yan,Liu, Ming-Hui,Jia, Ning-Yang,Miao, Zhen-Yuan,Zhang, Wan-Nian,Sheng, Chun-Quan,Yao, Jian-Zhong

, p. 623 - 626 (2016)

Ten new water-soluble amino acid conjugates of pyropheophorbide-a ethers 4a-4j were synthesized and investigated for their in vitro photodynamic antitumor activity. The results showed that all compounds exhibited higher phototoxicity and lower dark toxicity against three kinds of tumor cell lines than BPD-MA. In particular, the most phototoxic compound 4d and 4j individually showed IC50 values of 41 nmol/L and 33 nmol/L against HCT116 cell, which represented 7.8- and 9.7-fold increase of antitumor potency compared to BPD-MA, respectively, suggesting that they were promising photosensitizers for PDT applications because of their strong absorption at long wavelength (λmax > 650 nm), high phototoxicity, low dark cytotoxicity and good water-solubility.

Effects of noncovalently bound quinones on the ground and triplet states of zinc chlorins in solution and bound to de novo synthesized peptides

Mennenga, Anke,Gaertner, Wolfgang,Lubitz, Wolfgang,Goerner, Helmut

, p. 5444 - 5453 (2006)

The Qy absorption band of two chlorophyll derivatives, zinc chlorin e6 (ZnCe6) and zinc pheophorbide a (ZnPheida), in aqueous solution is bathochromically shifted on addition of quinones, e.g., 1,4-benzoquinone (BQ), with a corresponding shift of the fluorescence band. This is due to a complex formation of zinc chlorins induced by BQs and subsequent rearrangement. The time-resolved absorption spectra after laser pulse excitation show triplet quenching of the pigments by BQ and other quinones via electron transfer. The effects of electron transfer to noncovalently bound BQs were also studied with de novo synthesized peptides, into which ZnCe6 and ZnPheida were incorporated as model systems for the primary steps of photosynthetic reaction centers. Whereas the photophysical properties are similar to those of the unbound zinc chlorins, no BQ-mediated complex formation was observed. the Owner Societies.

Design and synthesis of novel water-soluble amino acid derivatives of chlorin p6 ethers as photosensitizer

Zhang, Xingjie,Meng, Zhi,Ma, Zhiqiang,Liu, Junhong,Han, Guiyan,Ma, Fujia,Jia, Ningyang,Miao, Zhenyuan,Zhang, Wannian,Sheng, Chunquan,Yao, Jianzhong

, p. 247 - 249 (2019)

Eight new water-soluble amino acid conjugates 6a-h of chlorin p6 ethers (5a-d) were synthesized and preliminarily investigated for their in vitro PDT antitumor activity and structure-activity relationship (SAR). The results showed that all compounds exhibited much higher phototoxicity against tumor cells than talaporfin. SAR analysis indicated that PDT antitumor effect enhanced with the increase of carbon chain length of alkoxyl ether bonds at 31-position, and L-aspartic acid was superior to L-glutamic acid. In particular, the IC50 values of most phototoxic compound 6d were 0.20 μmol/L against A549 cell and 0.41 μmol/L against B16-F10 cell, which individually represented 31- and 24-fold increase of antitumor potency compared to talaporfin, suggesting that it was a promising candidate photosensitizer (PS) for PDT applications due to its strong absorption at long wavelength, high phototoxicity, low dark cytotoxicity and good water-solubility.

Semi-synthesis and HPLC analysis of (bacterio)chlorophyllides possessing a propionic acid residue at the C17-position

Teramura, Misato,Tamiaki, Hitoshi

, p. 423 - 436 (2018)

Various chlorophyll and bacteriochlorophyll derivatives possessing a magnesium or zinc atom at the central position and a free carboxylic acid group at the C172-position, also known as (bacterio)chlorophyllides, were synthesized through a combination of organic synthesis techniques and enzymatic steps. The semi-synthetic (bacterio)chlorophyllides were purified and analyzed using reversed-phase high-performance liquid chromatography with UV-vis spectroscopy and mass spectrometry. These free propionic acid-containing chlorophyllous pigments can be useful research materials for the study of (bacterio)chlorophyll metabolisms.

Novel chlorin e4 derivative, pharmaceutically acceptable salt thereof, and preparation methods and application of novel chlorin e4 derivative and thepharmaceutically acceptable salt thereof

-

Page/Page column 14, (2021/10/27)

The invention belongs to the technical field of medicines, and relates to a novel chlorin e4 derivative and pharmaceutically acceptable salts thereof, and preparation methods and application of the novel chlorin e4 derivative and thepharmaceutically acceptable salt thereof. The chlorin e4 derivative comprises a structure shown as a general formula I and an optical isomer contained in the structural general formula I; according to the preparation method, 17-propionyl or 13-formyl in chlorin e4 and amino acid are subjected to peptide formation and/or 3-vinyl etherification. The chlorin e4 derivative and the pharmaceutically acceptable salt thereof can be applied as a photodynamic antitumor drug. Compared with the existing similar photosensitizer talaporfin which is clinically applied, the chlorin e4 derivative disclosed by the invention has the advantages of strong photodynamic antitumor activity, high dark toxicity-light toxicity ratio and the like; the derivative can be used for preparing novel photodynamic antitumor drugs including photodynamic cancer treatment drugs, drugs for photodynamic treatment of benign vascular diseases such as age-related macular degeneration and nevus flammeus and drugs for photodynamic treatment of condyloma acuminata.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15664-29-6